|
2024-08-15 |
2024-08-13 |
B
Purchase
|
Large shareholder
|
18,006
+45.0%
11.73
US$1,789,063
|
18,006
+45.0%
|
11.73
|
US$1,789,063
|
|
|
2024-08-15 |
2024-08-13 |
B
Purchase
|
Large shareholder
|
19,942
-23.5%
266.44
US$4,457,478
|
19,942
-23.5%
|
266.44
|
US$4,457,478
|
|
|
2022-11-29 |
2022-11-25 |
B
Purchase
|
Large shareholder
|
99,399
-21.8%
249.63
US$3,162,972
|
99,399
-21.8%
|
249.63
|
US$3,162,972
|
|
|
2022-10-11 |
2022-10-10 |
S
Sale
|
Large shareholder
|
87,036
-17.5%
4.09
US$355,977
|
87,036
-17.5%
|
4.09
|
US$355,977
|
|
|
2022-10-11 |
2022-10-10 |
S
Sale
|
Large shareholder
|
19,017
-17.0%
4.09
US$77,780
|
19,017
-17.0%
|
4.09
|
US$77,780
|
|
|
2022-10-11 |
2022-10-10 |
S
Sale
|
Large shareholder
|
456,413
-17.0%
4.09
US$1,866,729
|
456,413
-17.0%
|
4.09
|
US$1,866,729
|
|
|
2022-10-11 |
2022-10-06 |
S
Sale
|
Large shareholder
|
5,808
-1.2%
5.02
US$29,156
|
5,808
-1.2%
|
5.02
|
US$29,156
|
|
|
2022-10-11 |
2022-10-06 |
S
Sale
|
Large shareholder
|
1,269
-1.1%
5.02
US$6,370
|
1,269
-1.1%
|
5.02
|
US$6,370
|
|
|
2022-10-11 |
2022-10-06 |
S
Sale
|
Large shareholder
|
30,457
-1.1%
5.02
US$152,894
|
30,457
-1.1%
|
5.02
|
US$152,894
|
|
|
2022-09-08 |
2022-09-07 |
S
Sale
|
Large shareholder
|
30,173
-5.7%
4.75
US$143,322
|
30,173
-5.7%
|
4.75
|
US$143,322
|
|
|
2022-09-08 |
2022-09-07 |
S
Sale
|
Large shareholder
|
6,793
-5.7%
4.75
US$32,267
|
6,793
-5.7%
|
4.75
|
US$32,267
|
|
|
2022-09-08 |
2022-09-07 |
S
Sale
|
Large shareholder
|
163,034
-5.7%
4.75
US$774,412
|
163,034
-5.7%
|
4.75
|
US$774,412
|
|
|
2022-09-08 |
2022-09-06 |
S
Sale
|
Large shareholder
|
4,016
-0.7%
5.52
US$22,168
|
4,016
-0.7%
|
5.52
|
US$22,168
|
|
|
2022-09-08 |
2022-09-06 |
S
Sale
|
Large shareholder
|
904
-0.7%
5.52
US$4,990
|
904
-0.7%
|
5.52
|
US$4,990
|
|
|
2022-09-08 |
2022-09-06 |
S
Sale
|
Large shareholder
|
21,702
-0.7%
5.52
US$119,795
|
21,702
-0.7%
|
5.52
|
US$119,795
|
|
|
2022-04-13 |
2022-04-11 |
S
Sale
|
Large shareholder
|
40,733
-7.0%
5.00
US$203,665
|
40,733
-7.0%
|
5.00
|
US$203,665
|
|
|
2022-04-13 |
2022-04-11 |
S
Sale
|
Large shareholder
|
9,171
-7.0%
5.00
US$45,855
|
9,171
-7.0%
|
5.00
|
US$45,855
|
|
|
2022-04-13 |
2022-04-11 |
S
Sale
|
Large shareholder
|
220,096
-7.0%
5.00
US$1,100,480
|
220,096
-7.0%
|
5.00
|
US$1,100,480
|
|
|
2021-12-06 |
2021-12-03 |
B
Purchase
|
President and CEO
Executive Director
|
10,000
+27.1%
3.96
US$39,553
|
10,000
+27.1%
|
3.96
|
US$39,553
|
|
|
2021-12-06 |
2021-12-03 |
B
Purchase
|
Non-Executive Director
|
5,000
+inf%
3.91
US$19,569
|
5,000
+inf%
|
3.91
|
US$19,569
|
|
|
2021-03-16 |
2021-03-15 |
S
Sale
|
Large shareholder
|
110,588
-3.9%
7.03
US$777,788
|
110,588
-3.9%
|
7.03
|
US$777,788
|
|
|
2021-03-16 |
2021-03-12 |
S
Sale
|
Large shareholder
|
39,469
-1.4%
7.22
US$284,816
|
39,469
-1.4%
|
7.22
|
US$284,816
|
|
|
2020-05-28 |
2020-05-26 |
B
Purchase
|
Large shareholder
|
578,034
+inf%
8.65
US$4,999,994
|
578,034
+inf%
|
8.65
|
US$4,999,994
|
|
|
2020-05-26 |
2020-05-21 |
B
Purchase
|
Large shareholder
|
231,200
+inf%
8.65
US$1,999,880
|
231,200
+inf%
|
8.65
|
US$1,999,880
|
|
|
2020-05-26 |
2020-05-21 |
B
Purchase
|
Large shareholder
|
1,156,083
+33.9%
8.65
US$10,000,118
|
1,156,083
+33.9%
|
8.65
|
US$10,000,118
|
|
|
2020-02-19 |
2020-02-14 |
B
Purchase
|
Large shareholder
|
271,993
+9.1%
8.20
US$2,230,343
|
271,993
+9.1%
|
8.20
|
US$2,230,343
|
|
|
2019-12-17 |
2019-12-13 |
B
Purchase
|
Tucker John H
President and CEO
Executive Director
|
5,000
+inf%
5.24
US$26,188
|
5,000
+inf%
|
5.24
|
US$26,188
|
|
|
2019-04-15 |
2019-04-11 |
B
Purchase
|
Large shareholder
|
389,862
+13.6%
2.70
US$1,052,627
|
389,862
+13.6%
|
2.70
|
US$1,052,627
|
|
|
2017-11-24 |
2017-11-21 |
B
Purchase
|
SUN PHARMACEUTICAL INDUSTRIES LTD
Large shareholder
|
357,143
+inf%
14.00
US$5,000,002
|
357,143
+inf%
|
14.00
|
US$5,000,002
|
|
|
2017-11-21 |
2017-11-21 |
B
Purchase
|
5AM Partners IV, LLC
Large shareholder
|
26,190
+25.2%
14.00
US$366,660
|
26,190
+25.2%
|
14.00
|
US$366,660
|
|
|
2017-11-21 |
2017-11-21 |
B
Purchase
|
5AM Partners IV, LLC
Large shareholder
|
628,572
+25.2%
14.00
US$8,800,008
|
628,572
+25.2%
|
14.00
|
US$8,800,008
|
|
|
2017-11-21 |
2017-11-21 |
B
Purchase
|
ORBIMED ADVISORS LLC
Large shareholder
|
833,333
+32.3%
14.00
US$11,666,662
|
833,333
+32.3%
|
14.00
|
US$11,666,662
|
|
|
2017-11-21 |
2017-11-21 |
B
Purchase
|
Lundbeckfond Invest A/S
Large shareholder
|
654,762
+25.9%
14.00
US$9,166,668
|
654,762
+25.9%
|
14.00
|
US$9,166,668
|
|